The hepatitis B therapeutics market size was valued at USD 2.48 billion in 2025 and is projected to grow from USD 2.76 billion in 2026 to USD 7.54 billion by 2034 at a CAGR of 11.85% during the forecast period (2026-2034), as per Straits Research analysis.
Key Highlights
North America dominated the global hepatitis B therapeutics market.
Asia-Pacific is expected to be the...
The Anti-Infective Drugs Market continues to play a foundational role in global healthcare systems, addressing a broad spectrum of bacterial, viral, fungal, and parasitic infections. Valued at US$ 134,267.21 Million in 2024, the market is projected to expand at a CAGR of 3.1% from 2025 to 2032. Despite moderate growth, sustained demand is supported by rising infectious disease prevalence,...
The Recombinant Protein Therapeutics CDMO Market is gaining substantial momentum as pharmaceutical and biotechnology companies increasingly outsource complex biologics manufacturing to specialized contract development and manufacturing organizations (CDMOs). Valued at USD 20,920.32 million in 2024, the market is projected to expand at a robust CAGR of 13.98% from 2025 to 2032. Growth is driven...
The Hepatocyte Growth Factors (HGFs) Market is witnessing significant growth as global healthcare and biotechnology sectors increasingly leverage HGFs for research, therapeutic development, and clinical applications. Valued at US$ 71,786.23 million in 2024, the market is projected to grow at a CAGR of 5.6% from 2025 to 2032. This growth is fueled by rising prevalence of liver disorders,...
[Hyderabad, 21 June 2025] – The North America Infectious Disease Therapeutics Market is set to experience robust growth over the next decade, projected to rise from USD 38.2 billion in 2024 to USD 67.5 billion by 2032, expanding at a CAGR of 7.1%. This growth trajectory is propelled by increasing infectious disease prevalence, rapid advancements in therapeutics, and strategic investment...
[Hyderabad, 21 June 2025] – The North America Infectious Disease Therapeutics Market is set to experience robust growth over the next decade, projected to rise from USD 38.2 billion in 2024 to USD 67.5 billion by 2032, expanding at a CAGR of 7.1%. This growth trajectory is propelled by increasing infectious disease prevalence, rapid advancements in therapeutics, and strategic investment...
[Hyderabad, 21 June 2025] – The Middle East and Africa (MEA) Infectious Disease Therapeutics Market is forecast to grow steadily over the next decade, reaching USD 15.3 billion by 2032, up from USD 8.4 billion in 2024, reflecting a CAGR of 7.7% during the forecast period (2024–2032). This expansion is fueled by a growing disease burden, increased healthcare investments, and enhanced...
Latin America Infectious Disease Therapeutics Market to Reach USD 18.7 Billion by 2032 Amid Rising Disease Burden and Advancements in Drug Development
[Hyderabad, 21 June 2025] - The Latin America Infectious Disease Therapeutics Market is poised for substantial growth, projected to increase from USD 10.2 billion in 2024 to USD 18.7 billion by 2032, registering a CAGR of 7.8% during the...
[Hyderabad, 21 June 2025] – According to a recent industry report, the Europe Infectious Disease Therapeutics Market is projected to grow significantly, reaching USD 51.2 billion by 2032, up from USD 28.4 billion in 2024, expanding at a robust CAGR of 7.6% during the forecast period (2024–2032). This growth is underpinned by an increasing prevalence of infectious diseases, rising...
[Hyderabad, 21 June 2025] – According to a recent industry report, the Europe Infectious Disease Therapeutics Market is projected to grow significantly, reaching USD 51.2 billion by 2032, up from USD 28.4 billion in 2024, expanding at a robust CAGR of 7.6% during the forecast period (2024–2032). This growth is underpinned by an increasing prevalence of infectious diseases, rising...
Executive Summary Middle East and Africa Industrial Controller Market :
Data Bridge Market Research analyses that the Middle East and Africa industrial controller market is expected to reach USD 16.64 billion by 2032 from USD 10.25 billion in 2024, growing with a CAGR of 6.4% in the forecast period of 2025 to 2032
This Middle East and Africa Industrial Controller Market report...
Executive Summary Methyl Methacrylate (MMA) Resin Market :
Global methyl methacrylate (MMA) resin market size was valued at USD 8.61 billion in 2024 and is projected to reach USD 11.97 billion by 2032, with a CAGR of 4.20% during the forecast period of 2025 to 2032.
The comprehensive Methyl Methacrylate (MMA) Resin Market research report is organized by collecting market...